Effective treatment. Changing lives Treatment Outcomes Profile (TOP) Level 3 TOP Outcomes Report Important notes November 2009.

Slides:



Advertisements
Similar presentations
How to use the DET (Data Entry Tool) Core data Set H.
Advertisements

How to use the DET (Data Entry Tool) Core data Set J.
Welcome to CSAW Authorization Management April 2008.
Interactive Drug Search Application Tutorial All Content ©2006 Health Alliance Plan.
RAJAR Website Training Manual Berlin: March 2013.
March/ April 2014 Gerry Flaherty, Margaret Gun and Kathryn McChrystal
ALB-3 Paper 1 Headline Measures and Business Intelligence Data Pack.
Introduction to OBIEE:
Orchard Harvest™ LIS Review Results Training
Reference Guide Module 4: Reports October 2014 Reference Guide Module 4: Reports October 2014.
Revenue Cycle Benchmarking Going Beyond… To Improve Revenue Cycle Outcomes Presented by: Frank Giannantonio President.
Do consumers of ecstasy-type pills take preventative measures to avoid bad effects from ecstasy-type pills? Dr Fairlie McIlwraith Associate Professor Rosa.
Manitoba Speech-Language Pathology Outcomes Measure A Supervisor’s Step by Step Guide to Navigating the Manitoba Speech-Language Pathology Outcomes Measure.
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
Microsoft Office 2007 Access Chapter 2 Querying a Database.
Procurement Card Training Strategic Account Management (SAM)
1 Introduction to OBIEE: Learning to Access, Navigate, and Find Data in the SWIFT Data Warehouse Lesson 5: Navigation in OBIEE – Touring the Catalog Page.
CareFirst New Reporting Features. OperationalPerformance The Team Manager Dashboard and Practitioner Dashboard reports have merged under the new title.
Maintenance of Effort (MOE) Excess Cost Presenter Patricia Holcomb-Gray Office of Special Education Programs NJ Department of Education June 3, 2015.
1. 2 Overview of AT&T EPIC Ordering Process for SUS (Supply Order) Suppliers 1.AT&T User creates shopping cart on internal web-based portal 2.Shopping.
NCSRA Arbiter Payroll Creation Tutorial Prepared by Paul James State Youth Referee Administrator Copyright ©2007.
Forecasting inflation; The Fan Chart CCBS/HKMA May 2004.
Workforce Engagement Survey Accessing your survey results and focussing on key messages in the survey data.
PPMR Provider Performance Management Review How to Navigate and Read PPMR Reports Press the F5 key on your keyboard to begin Click to advance to the next.
CSA Release 2 CYBER Training. Training Purpose Review the new functionality in CYBER that will assist in the submission and review of Treatment Plans.
What have others said or recommended, as their part of “Participating in the Process?” What have others said or recommended, as their part of “Participating.
NATMS Overview Kevin Shelton Treatment Information Manager 2 June 2009.
Declining Market Seller Pricing Strategies “The Seller’s Dilemma!” Copyright © Mike Wardley, 2008.
What is Sure BDCs? BDC stands for Batch Data Communication and is also known as Batch Input. It is a technique for mass input of data into SAP by simulating.
1 MySQL and phpMyAdmin. 2 Navigate to and log on (username: pmadmin)
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
We Are Learning To (WALT): Evaluate existing web graphics What I am Looking For (WILF): 4 evaluations that contain: – Detailed descriptions of target.
PassMeritDistinction Candidates will collect and display examples of: navigation buttons navigation bar advertising banner from at least two different.
Moodle (Course Management Systems). Assignments 1 Assignments are a refreshingly simple method for collecting student work. They are a simple and flexible.
Welcome to the Manage Inventory lesson for the North Carolina Immunization Branch. Contents: Adding Inventory Modifying Inventory Inventory Reports **
SIGNZ V3.39 Centre Proposals SIGNZ V3.39 Centre Proposals.
Introductory Statistics Week 4 Lecture slides Exploring Time Series –CAST chapter 4 Relationships between Categorical Variables –Text sections.
Decision Support Tools. Decision Support: About This Presentation Employee engagement in benefit enrollment decisions is an important part of our enrollment.
To Join a Team, click the “Join a Team” button.. Once on the page, click one of the two “Join Team” buttons on the page to begin the registration process.
Effective treatment. Changing lives Treatment Outcomes Profile (TOP) Overview of TOP reports January 2010.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
“The Monitor" System Training Guide For Providers IMS Health.
© ABB Group November 16, 2015 | Slide 1 Stock Book User Guide Low Voltage Products Trevor Kirtley, Stock Book 11 February 2009.
Comprehensive Field Record. Introduction to the Training ● The slides will first show a picture of the section of the template that will be discussed.
1 Sponsor Claim Process  Click on the Sponsor Claims menu in order to process claims.  The submenu will display: Sponsor Claims will display the most.
Office of Housing Choice Voucher Program Voucher Management System – VMS Version Released October 2011.
Pinchmill Lower School Assessment in the New Curriculum November 2015.
Transformation Accountability (TRAC) Center for Mental Health Services November 2015 Version 6 NOMs Client-level Measures for Programs Providing Direct.
Proposal Processing Proposals, Staffing Profiles, Financial Summary Hewlett-Packard Project & Portfolio Management Project & Portfolio Management Slide.
PestPac Software. Leads The Leads Module allows you to track all of your pending sales for your company from the first contact to the close. By the end.
Sampling Design and Analysis MTH 494 Lecture-21 Ossam Chohan Assistant Professor CIIT Abbottabad.
Proposal Processing Proposals, Staffing Profiles, Financial Summary Hewlett-Packard Project & Portfolio Management Project & Portfolio Management Slide.
Effective treatment. Changing lives Treatment Outcomes Profile (TOP) Overview of TOP reports February 2010.
Critical Appraisal Course for Emergency Medicine Trainees Module 3 Evaluation of a therapy.
Mortgage Holding & Switching Market Research Findings Section 1 - Face to Face Survey Section 2 - Online Survey 1 Research Conducted by.
Applying for Scholarships with Mora Dollars for Scholars
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
Welcome to HICAPS CSS!.
Annual Performance Management Cycle Management Training Tutorial
Creating Oracle Business Intelligence Interactive Dashboards
Key Performance Indicators
Access Chapter 2 Querying a Database.
How to Start This PowerPoint® Tutorial
This is a setup file for a Jeopardy game.
This is a setup file for a Jeopardy game.
Степень с натуральным показателем
For a step-by-step tour of this process, press space bar to continue.
This is a setup file for a Jeopardy game.
FAFSA on the Web Simplification
Presentation transcript:

Effective treatment. Changing lives Treatment Outcomes Profile (TOP) Level 3 TOP Outcomes Report Important notes November 2009

Effective treatment. Changing lives Contents  Performance management warning Performance management warning  How to use these notes How to use these notes  Examples of how to use these notes Examples of how to use these notes  Eligibility criteria Eligibility criteria  Eligible Partnerships Eligible Partnerships  Outcomes in Problematic Substances Outcomes in Problematic Substances  Outcomes in Substances Used Outcomes in Substances Used  Outcomes in Injecting behaviour Outcomes in Injecting behaviour  Outcomes in Crime Outcomes in Crime  Outcomes in Health and Social Functioning Outcomes in Health and Social Functioning

Effective treatment. Changing lives This is the first level three outcomes report and it should not be used for delivery assurance  The information contained in the Level 3 Outcomes report should NOT be used for the purpose of delivery assurance. This will begin quarter 1 in 2010/11.  Therefore this data is provided for information purposes only because:  There is only one quarters data  There are some small numbers, especially at Provider level (this makes percentage comparisons difficult)  The information has not been adjusted for the differential case mix of client profiles in different partnerships (to ensure like for like comparisons)  No performance metrics have yet been established against which performance could be said to be good or not  All data is RESTRICTED and should not be disseminated beyond the partnership or provider Contents

Effective treatment. Changing lives How to utilise these notes  We have continued to receive requests from the field for guidance on the TOP reports and what they mean  Dense word documents have not proved to be the best way to communicate information. People either don’t have time to read or find them confusing and difficult to follow  This PowerPoint pack aims to communicate the information in a simple, interactive and effective format.  To keep the number of slides needed to communicate all the information the following slides have been animated. This makes the pack difficult to print and you will need to view it in ‘slide show mode’.  Each slide is linked to the contents page, so you can easily navigate through the different sections – just click the contents button in the top right hand corner of any slide and it will take you back  We suggest several ways that this information can be used – these are shown in the slides to follow Contents

Effective treatment. Changing lives This format can be used in a variety of different ways. Two of the most common ways are shown here Print the actual Level 3 Outcomes report not the notes. Open the PowerPoint notes on your PC Select slide show mode Press ‘enter’ to move through the notes You can then go through your report at your own pace in combination with the PowerPoint notes The Level 3 Outcome report notes can be used in the ‘traditional format’ as an aid to a verbal presentation. Or, several reports can be printed and all persons can run through the reports & explanatory notes in a group This might be useful if the information needs to be communicated to a group of people. + = Contents

Effective treatment. Changing lives There are five key eligibility criteria used to define the clients included in the level 3 outcomes  They started a treatment journey in Quarter /09  They were in treatment for at least 6 months  They were to be aged 18 and over at triage  They had a TOP reported within +/- two weeks of starting treatment  They had a TOP reported between 5 and 26 weeks after starting treatment Contents

Effective treatment. Changing lives There are currently 46 Partnerships who have met the eligibility criteria and can access the Level 3 Outcomes Report (all providers in the partnership area also have access) Eligible Partnerships BarnetDudleyLincolnshireStockton-on-Tees Bath and North East Somerset EalingMedway townsTelford and Wrekin BedfordshireEnfieldMiddlesbroughTorbay BirminghamEssexMilton KeynesTower Hamlets Blackburn with DarwenHackneyNewhamTrafford BradfordHammersmith and Fulham North East LincolnshireWakefield City of LondonHartlepoolNorth LincolnshireWaltham Forest CoventryHaveringNottinghamshireWarrington DerbyHertfordshirePlymouthWestminster DevonIsle of WightSalfordYork DoncasterKentSolihull DorsetKingston Upon HullStaffordshire Contents

Effective treatment. Changing lives These figures show the average number of days using a drug – in those who were using it at the Start of treatment – in the 28 days preceding their Review in the 5-26 weeks after treatment started These figures provide a summary of the difference between the average level of use at the Start of treatment compared to the average level of use at Review The first section of the Outcomes report only considers clients who cited a particular drug as problematic at triage These drugs were cited by the client as problematic (Drug 1, 2 or 3) when they started treatment These figures document the number (%) of people who were not using the drug when they entered treatment but who subsequently report using it by the time of the Review ‘Number of valid TOP pairs’ is the number of clients (who said they had a problem with a particular substance) who gave a response on TOP at Start and Review that was between 0 & 28 ‘Number using at baseline’ is the number of people who returned a valid TOP pair who were using 1 to 28 days in the month preceding the Start of treatment ‘% Using at baseline’ is the number of people using a substance divided by the number of valid TOP pairs. It may be prudent to question why this percentage is not 100% These figures represent the average number of days the users of a drug were consuming that drug in the 28 days prior to the Start of treatment. Comparisons with regional and national figures give an estimate of the relative problem in the Partnership Of those who were using a substance at the Start of treatment, this percentage shows the proportion of the group who were not using the drug in the 28 days prior to their Review Are these as expected? Are there large differences here? Are reductions better or worse than regional and national levels? How do abstinence levels compare to regional and national levels? Are these levels as expected? Cannabis use is lower in this Partnership than Regional / National Levels Average reduction in use is less in this Partnership. Is there a reason? What about the other drugs? Contents

Effective treatment. Changing lives These figures show the average number of days using a drug – in those who were using it at the Start of treatment – in the 28 days preceding their Review in the 5-26 weeks after treatment started These figures provide a summary of the difference between the average level of use at the Start of treatment compared to the average level of use at Review These drugs are not dependent on being cited as problematic at Triage These figures document the number (%) of people who were not using the drug when they entered treatment but who subsequently report using it by the time of the Review ‘Number of valid TOP pairs’ is the number of clients (regardless of whether they had a problem with a particular substance) who gave a response on TOP at Start and Review that was between 0 & 28 Of those who were using a substance at the Start of treatment, this percentage shows the proportion of the group who were not using the drug in the 28 days prior to their Review ‘Number using at baseline’ is the number of people who returned a valid TOP pair who were using 1 to 28 days in the month preceding the Start of treatment ‘% Using at baseline’ is the number of people using a substance divided by the number of valid TOP pairs. These figures represent the average number of days the users of a drug were consuming that drug in the 28 days prior to the Start of treatment. Comparisons with regional and national figures give an estimate of the relative problem in the Partnership Section 1 considers all drug use, reported using the TOP. This is not dependent on it being cited as problematic at triage These proportions give information about the prevalence of substances in clients accessing treatment in the Partnership or Provider. One might want to compare these figures against the numbers reported when a drug is cited as problematic e.g. crack Cited as problematic Reported as used Why the large difference? Could some of the 157 be extra ‘crack PDUs’ in this Partnership? Contents

Effective treatment. Changing lives Section 2 reports on injecting risk behaviour and receptive sharing of injecting paraphernalia as reported on the TOP The report on injecting risk behaviour follows the same format as Section 1. The number of pairs that can be analysed The number reporting the behaviour % of injectors is the number reporting injecting over the number of valid pairs % who share is obtained by dividing the numbers of sharers by baseline injectors These two sections give the Partnership (or Provider) Regional and National comparison figures Frequency of injecting Proportion of injectors sharing This section provides a summary of the amount of reduction in the frequency (above) and proportion (below) of injecting and sharing This section shows the proportion of injectors who were no longer injecting by the 6 month review The final section reports the number and % of those who have started to inject Contents

Effective treatment. Changing lives Section 3 reports on the crime information that has been reported using the TOP. Are these levels of reported crime as expected for this Partnership or Provider? How do the frequencies or proportions compare to Regional and National figures? How do reductions compare to Regional and National reductions? Are the levels of those no longer reporting shoplifting or drug selling in line with comparators? Contents

Effective treatment. Changing lives Section 4 reports on the health and social functioning that was reported by clients on the TOP Consider PAID WORK 11.1% of those entering this Partnership were working at the start of treatment They were working just over 21 days on average in the previous 28 At Review, ¼ were no longer working (~¼ of 35 workers is 9) This REDUCED average working by about 6 days BUT 29 individuals started work in the same period This translates into a net gain of 20 workers in this Partnership in 6 months – nearly a 60% increase NB: these figures must be digested slowly Same pattern applies – in this example – to education Acute housing problems and housing risk decrease Health and social functioning also increase by 6 months Contents

Effective treatment. Changing lives Remember this information should not be used for delivery assurance Contents  The information contained in the Level 3 Outcomes report should NOT be used for the purpose of delivery assurance. This will begin quarter 2010/11.  Therefore this data is provided for information purposes only because:  There is only one quarters data  There are some small numbers, especially at Provider level (this makes percentage comparisons difficult)  The information has not been adjusted for the differential case mix of client profiles in different partnerships (to ensure like for like comparisons)  No performance metrics have yet been established against which performance could be said to be good or not  All data is RESTRICTED and should not be disseminated beyond the partnership or provider